Retrospective Study
Copyright ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Hepatol. Jun 27, 2018; 10(6): 425-432
Published online Jun 27, 2018. doi: 10.4254/wjh.v10.i6.425
Paracentesis in cirrhotics is associated with increased risk of 30-day readmission
Lindsay A Sobotka, Rohan M Modi, Akshay Vijayaraman, A James Hanje, Anthony J Michaels, Lanla F Conteh, Alice Hinton, Ashraf El-Hinnawi, Khalid Mumtaz
Lindsay A Sobotka, Rohan M Modi, Akshay Vijayaraman, Department of Internal Medicine, the Ohio State University Wexner Medical Center, Columbus, OH 43210, United States
A James Hanje, Anthony J Michaels, Lanla F Conteh, Khalid Mumtaz, Division of Gastroenterology, Hepatology and Nutrition, the Ohio State Wexner Medical Center, Columbus, OH 43210, United States
Alice Hinton, Division of Biostatistics, College of Public Health, the Ohio State University, Columbus, OH 43210, United States
Ashraf El-Hinnawi, Department of Surgery, the Ohio State Wexner Medical Center, Columbus, OH 43210, United States
Author contributions: Sobotka LA, Modi RM, Vijayaraman A and Mumtaz K analyzed the data, drafted the manuscript and revised for important intellectual content; Hinton A performed the statistical analysis; Hanje AJ, Michaels AJ, Conteh LF and El-Hinnawi A revised for important intellectual content; Mumtaz K supervised the study.
Institutional review board statement: The Ohio State University Data and Specimen Policy and Human Subjects Research Policy do not require Institutional Board Review approval for population-based public data sets. Per 45 Code of Federal Regulations (CFR 46.101), research using certain publicly available data sets does not involve “human subjects.”
Informed consent statement: The Ohio State University Data and Specimen Policy and Human Subjects Research Policy do not require informed consent for research conducted using publicy available data set as they do not involve “human subject.”
Conflict-of-interest statement: None of the authors have conflicts of interest.
Data sharing statement: No additional data is available
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Khalid Mumtaz, MD, MSc, Assistant Professor, Doctor, Division of Gastroenterology, Hepatology and Nutrition, the Ohio State Wexner Medical Center, 95 West 12th Avenue, 2nd Floor, Columbus, OH 43210, United States. khalid.mumtaz@osumc.edu
Telephone: +1-614-2931456 Fax: +1-614-2936720
Received: December 22, 2018
Peer-review started: December 22, 2018
First decision: March 8, 2018
Revised: March 13, 2018
Accepted: April 11, 2018
Article in press: April 11, 2018
Published online: June 27, 2018
Processing time: 132 Days and 4.2 Hours
Core Tip

Core tip: Cirrhotic patients with ascites have a 33% chance of 30-d readmission. Factors associated with 30-d readmission include age < 64 years, Medicaid and Medicare insurance, increased comorbidities, nonalcoholic cirrhosis, hepatocellular carcinoma and paracentesis during index admission. Based on identification of these predictors and significant cost involvement, there is need to find ways to counteract them and reduce 30-d readmission rate.